Indication
Hyperparathyroidism secondary to chronic renal failure
Hyperparathyroidism secondary to chronic renal failure is a systemic mineral and endocrine disorder characterized by excessive parathyroid hormone secretion and parathyroid gland hyperplasia occurring in response to declining kidney function. Read more about Hyperparathyroidism secondary to chronic renal failure
51 drugs 35 manufacturers
Drugs that treat it
Common Hyperparathyroidism secondary to chronic renal failure therapies.
CALCITRIOL
CALCITRIOL
CALCITRIOL
DOXERCALCIFEROL
CALCITRIOL
CALCITRIOL
PARICALCITOL
CALCITRIOL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHyperparathyroidism secondary to chronic renal failure is a systemic mineral and endocrine disorder characterized by excessive parathyroid hormone secretion and parathyroid gland hyperplasia occurring in response to declining kidney function.
Pathophysiologically, deteriorating renal clearance causes phosphate retention, reduced synthesis of active 1,25-dihydroxyvitamin D (calcitriol), and resultant hypocalcemia, which continuously stimulate the parathyroid glands.
If unmanaged, this chronic hormonal and biochemical dysregulation affects the skeletal and cardiovascular systems, contributing to renal osteodystrophy, bone fractures, and vascular calcification.
- nih.gov
Hyperparathyroidism secondary to chronic renal failure is a systemic mineral and endocrine disorder characterized by excessive parathyroid hormone secretion and parathyroid gland hyperplasia occurring in response to declining kidney function Pathophysiologically, deteriorating renal clearance causes phosphate retention, reduced synthesis of active 1,25-dihydroxyvitamin D (calcitriol), and resultant hypocalcemia, which continuously stimulate the parathyroid glands
- nih.gov
Hyperparathyroidism secondary to chronic renal failure is a systemic mineral and endocrine disorder characterized by excessive parathyroid hormone secretion and parathyroid gland hyperplasia occurring in response to declining kidney function Pathophysiologically, deteriorating renal clearance causes phosphate retention, reduced synthesis of active 1,25-dihydroxyvitamin D (calcitriol), and resultant hypocalcemia, which continuously stimulate the parathyroid glands If unmanaged, this chronic hormo...
- nih.gov
Pathophysiologically, deteriorating renal clearance causes phosphate retention, reduced synthesis of active 1,25-dihydroxyvitamin D (calcitriol), and resultant hypocalcemia, which continuously stimulate the parathyroid glands
- nih.gov
If unmanaged, this chronic hormonal and biochemical dysregulation affects the skeletal and cardiovascular systems, contributing to renal osteodystrophy, bone fractures, and vascular calcification
- drugs.com
If unmanaged, this chronic hormonal and biochemical dysregulation affects the skeletal and cardiovascular systems, contributing to renal osteodystrophy, bone fractures, and vascular calcification
Personalize your experience
Follow Hyperparathyroidism secondary to chronic renal failure and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.